Sonendo Preliminary Estimates: 2025 Revenue Below Expectations, Dental Consumables and Services Account for 82% of Revenue

Image Source: Sonendo Official Website

Full-Year 2025 Revenue of $28.6M / Operating Loss Narrowed by 54% YoY / Anticipates Achieving Breakeven in H2 2026

DentalGoodNews｜March 16, 2026 - US-based endodontic technology company Sonendo, Inc. released its preliminary, unaudited financial results for the full year 2025. The company's total annual revenue was $28.6 million (approximately RMB 197 million), with recurring revenue from Consumables and services reaching $23.4 million (approximately RMB 161 million), accounting for about 82% of total revenue.

This revenue figure fell below the company's previously set guidance range. According to a prior report by DGN, Sonendo had set its full-year 2025 revenue guidance at $31 to $32 million (approximately RMB 213-220 million) in its Q2 2025 earnings report; the actual full-year revenue was about 8% below the lower end of that guidance. The company did not provide a separate explanation for missing the guidance in this announcement.

The gross margin for the full year 2025 increased to 41.9%, an improvement of 460 basis points compared to 2024.

Regarding operating loss, it decreased to $13.5 million (approximately RMB 92.97 million) in 2025, down from $29.4 million (approximately RMB 202 million) in 2024, representing a narrowing of approximately 54% year-over-year. Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) loss decreased from $23.0 million (approximately RMB 158 million) in 2024 to $10.4 million (approximately RMB 71.62 million) in 2025, narrowing by about 55%. Free cash flow burn decreased from $24.8 million (approximately RMB 171 million) in 2024 to $10.9 million (approximately RMB 75.07 million) in 2025, narrowing by about 56%.

CEO Bjarne Bergheim attributed these improvements to "rigorous operational improvements," stating that the company effectively reduced operating expenses while enhancing overall efficiency and successfully maintained its revenue base. Furthermore, the company's management indicated that it expects to achieve positive free cash flow and positive Adjusted EBITDA in the second half of 2026.

On the strategic front, on November 17, 2025, Sonendo entered into a strategic partnership with a Europe-based dental company (name undisclosed), securing exclusive rights to sell high-quality products in North America. This collaboration enables Sonendo to offer a more comprehensive endodontic Consumables product line. Management anticipates that this partnership will deliver significant cost savings for GentleWave customers, is expected to drive increased demand for GentleWave procedures, and will support revenue and gross margin growth.

As the first step in this strategic partnership, Sonendo launched the FlowLogic™ endodontic files in the first quarter of 2026. Management stated that the FlowLogic™ files are expected to compete with the best-performing files in the industry and will be offered to GentleWave system customers at a significant discount to reduce the per-procedure Consumables cost for each root canal treatment.